
Corporate
FDA Reverses Course, Will Review Moderna's mRNA Flu Vaccine
Feb 18
You're signed outSign in or to get full access.
Browse quarterly earnings call transcripts for Moderna.
Feb 13, 2026
Nov 6, 2025
Aug 1, 2025
May 1, 2025
Feb 14, 2025
Nov 7, 2024
Aug 1, 2024
May 2, 2024
Feb 22, 2024
Nov 2, 2023
Aug 3, 2023
May 4, 2023